The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis
Open accessAbstract
BACKGROUND: Colorectal cancer (CRC) is a leading cause of death in the United States. Increased level of interleukin-8 (IL-8) and CXCR2 on tumours and in the tumour microenvironment has been associated with CRC growth, progression and recurrence in patients. Here, we aimed to evaluate the effects of tissue microenvironment-encoded IL-8 and CXCR2 on colon cancer progression and metastasis. METHODS: A novel immunodeficient, skin-specific IL-8-expressing transgenic model was generated to evaluate colon cancer growth and metastasis. Syngeneic mouse colon cancer cells were grafted in CXCR2 knockout (KO) mice to study the contribution of CXCR2 in the microenvironment to cancer growth. RESULTS: Elevated levels of IL-8 in the serum and tumour microenvironment profoundly enhanced the growth of human and mouse colon cancer cells with increased peri-tumoural angiogenesis, and also promoted the extravasation of the cancer cells into the lung and liver. The tumour growth was inhibited in CXCR2 KO mice with significantly reduced tumour angiogenesis and increased tumour necrosis. CONCLUSION: Increased expression of IL-8 in the tumour microenvironment enhanced colon cancer growth and metastasis. Moreover, the absence of its receptor CXCR2 in the tumour microenvironment prevented colon cancer cell growth. Together, our study demonstrates the critical roles of the tumour microenvironment-encoded IL-8/CXCR2 in colon cancer pathogenesis, validating the pathway as an important therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Siegel, R., Ward, E., Brawley, O., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20121 · Cited by 4,070
The Interleukin-8 Pathway in Cancer
Waugh, D. J. J., & Wilson, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4843 · Cited by 2,103
Li, A., Dubey, S., Varney, M. L., Dave, B. J., & Singh, R. K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3369 · Cited by 1,332
The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis
Brat, D. J., Bellail, A. C., & Van Meir, E. G. (2005) · Neuro-Oncology · doi:10.1215/s1152851704001061 · Cited by 760
Optical imaging of Renilla luciferase reporter gene expression in living mice
Bhaumik, S., & Gambhir, S. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012611099 · Cited by 536
Hull, J. (2000) · Thorax · doi:10.1136/thorax.55.12.1023 · Cited by 515
Delayed Wound Healing in CXCR2 Knockout Mice
Devalaraja, R. M., Nanney, L. B., Qian, Q., Du, J., Yu, Y., Devalaraja, M. N., & Richmond, A. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00034.x · Cited by 429
Ning, Y., Manegold, P. C., Hong, Y. K., Zhang, W., Pohl, A., Lurje, G., Winder, T., Yang, D., LaBonte, M. J., Wilson, P. M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25562 · Cited by 406
Self-citationInduction of interleukin-8 preserves the angiogenic response in HIF-1α–deficient colon cancer cells
Mizukami, Y., Jo, W.-S., Duerr, E.-M., Gala, M., Li, J., Zhang, X., Zimmer, M. A., Iliopoulos, O., Zukerberg, L. R., Kohgo, Y., et al. (2005) · Nature Medicine · doi:10.1038/nm1294 · Cited by 406
Coussens, L. M., & Werb, Z. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.f23 · Cited by 384
Interleukin-8. A corneal factor that induces neovascularization.
Strieter, R. M., Kunkel, S. L., Elner, V. M., Mártonyi, C. L., Koch, A. E., Polverini, P. J., & Elner, V. M. (1992) · PubMed Central · Cited by 383
Vassar, R., Rosenberg, M., Ross, S., Tyner, A., & Fuchs, E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.5.1563 · Cited by 367
Influence of cytokine gene polymorphisms on the development of prostate cancer.
McCarron, S. L., Edwards, S. M., Evans, P. R., Gibbs, R., Dearnaley, D. P., Dowe, A., Southgate, C., Easton, D. F., Eeles, R. A., & Howell, W. M. (2002) · PubMed · Cited by 336
Kunstfeld, R., Hirakawa, S., Hong, Y.-K., Schacht, V., Lange-Asschenfeldt, B., Velasco, P., Lin, C., Fiebiger, E., Wei, X., Wu, Y., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2964 · Cited by 311
Self-citationDepletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer
Keane, M. P., Belperio, J. A., Xue, Y. Y., Burdick, M. D., & Strieter, R. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2853 · Cited by 305
Interleukin-8 Is a Molecular Determinant of Androgen Independence and Progression in Prostate Cancer
Araki, S., Omori, Y., Lyn, D., Singh, R. K., Meinbach, D. M., Sandman, Y., Lokeshwar, V. B., & Lokeshwar, B. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1162 · Cited by 275
Merritt, W. M., Lin, Y. G., Spannuth, W. A., Fletcher, M. S., Kamat, A. A., Han, L. Y., Landen, C. N., Jennings, N., De Geest, K., Langley, R. R., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn024 · Cited by 257
Ijichi, H., Chytil, A., Gorska, A. E., Aakre, M. E., Bierie, B., Tada, M., Mohri, D., Miyabayashi, K., Asaoka, Y., Maeda, S., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42754 · Cited by 256 · cited 1×
“More recently, CXCR2 inhibition was found to disrupt tumour–stromal interactions and also improve survival in a pancreatic ductal adenocarcinoma mouse model (Ijichi et al, 2011).”
BackgroundTaguchi, A., Ohmiya, N., Shirai, K., Mabuchi, N., Itoh, A., Hirooka, Y., Niwa, Y., & Goto, H. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0326 · Cited by 243
Molecular determinants of cetuximab efficacy.
Vallböhmer, D., Zhang, W., Gordon, M., Yang, D. Y., Yun, J., Press, O. A., Rhodes, K. E., Sherrod, A. E., Iqbal, S., Danenberg, K. D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.100 · Cited by 234
Self-citationOhyauchi, M., Imatani, A., Yonechi, M., Asano, N., Miura, A., Iijima, K., Koike, T., Sekine, H., Ohara, S., & Shimosegawa, T. (2005) · Gut · doi:10.1136/gut.2003.033050 · Cited by 230
Maxwell, P. J., Gallagher, R., Seaton, A., Wilson, C., Scullin, P., Pettigrew, J., Stratford, I. J., Williams, K. J., Johnston, P. G., & Waugh, D. J. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210536 · Cited by 199
Schultheis, A. M., Lurje, G., Rhodes, K. E., Zhang, W., Yang, D., Garcia, A. A., Morgan, R., Gandara, D., Scudder, S., Oza, A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0351 · Cited by 182
Self-citationInterleukln-8 stimulates angiogenesis in rats
Hu, D. E., Hori, Y., & Fan, T. P. D. (1993) · Inflammation · doi:10.1007/bf00916100 · Cited by 179
Lee, W.-P., Tai, D., Lan, K., Li, A. F., Hsu, H.-C., Lin, E.-J. D., Lin, Y.-P., Sheu, M., Li, C., Chang, F.-Y., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0942 · Cited by 155
Chapman, R. W., Minnicozzi, M., Celly, C. S., Phillips, J. E., Kung, T. T., Hipkin, R. W., Fan, X., Rindgen, D., Deno, G., Bond, R. W., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.119040 · Cited by 148
Paroo, Z., Bollinger, R. A., Braasch, D. A., Richer, E., Corey, D. R., Antich, P. P., & Mason, R. P. (2004) · Molecular Imaging · doi:10.1162/1535350041464865 · Cited by 143
Chen, L.-C., Hao, C., Chiu, Y. S. Y., Wong, P., Melnick, J., Brotman, M., Moretto, J. C., Mendes, F., Smith, A. P., Bennington, J. L., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3264 · Cited by 137
Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer
Lurje, G., Zhang, W., Schultheis, A. M., Yang, D., Groshen, S. G., Hendifar, A. E., Husain, H., Gordon, M. A., Nagashima, F., Chang, H.-M., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn368 · Cited by 135
Self-citationInterleukin‐8 modulates growth and invasiveness of estrogen receptor‐negative breast cancer cells
Yao, C., Lin, Y., Chua, M., Ye, C., Bi, J., Li, W., Zhu, Y., & Wang, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22930 · Cited by 132
Zhang, W., Gordon, M. A., Press, O. A., Rhodes, K. E., Vallböhmer, D., Yang, D., Park, D. S., Fazzone, W., Schultheis, A. M., Sherrod, A. E., et al. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000220562.67595.a5 · Cited by 122
Self-citationDwyer, M. P., Yu, Y., Chao, J., Aki, C., Chao, J., Biju, P., GIRIJAVALLABHAN, V. M., Rindgen, D., Bond, R. W., Mayer-Ezel, R., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0609622 · Cited by 120
Gerger, A., El-Khoueiry, A. B., Zhang, W., Yang, D., Singh, H., Bohanes, P. O., Ning, Y., Winder, T., LaBonte, M. J., Wilson, P. M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1115 · Cited by 92
Self-citationChemokines in human colorectal carcinoma.
Baier, P. K., Eggstein, S., Wolff-Vorbeck, G., Baumgartner, U., & Hopt, U. T. (2005) · PubMed · Cited by 81
Involvement of IL-8 in COX-2-Mediated Bone Metastases from Breast Cancer
Singh, B., Berry, J. A., Vincent, L., & Lucci, A. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2006.03.018 · Cited by 77
Genetic Variation in IL-8 Associated with Increased Risk and Poor Prognosis of Breast Carcinoma
Snoussi, K., Mahfoudh, W., Bouaouina, N., Ahmed, S. B., Helal, A. N., & Chouchane, L. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.03.018 · Cited by 71
GROα Is Highly Expressed in Adenocarcinoma of the Colon and Down-Regulates Fibulin-1
Wen, Y., Giardina, S. F., Hamming, D., Greenman, J., Zachariah, E., Bacolod, M. D., Liu, H., Shia, J., Amenta, P. S., Barany, F., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0736 · Cited by 58
GROα promotes invasion of colorectal cancer cells
Fukui (2010) · Oncology Reports · doi:10.3892/or_00001008 · Cited by 47
Cuenca, R. E., Azizkhan, R. G., & Haskill, S. (1992) · Surgical Oncology · doi:10.1016/0960-7404(92)90094-2 · Cited by 41
Cited by
Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
Ha, H., Debnath, B., & Neamati, N. (2017) · Theranostics · doi:10.7150/thno.15625 · Cited by 789
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
Yuen, K. C., Liu, L.-F., Gupta, V., Madireddi, S., Keerthivasan, S., Li, C., Rishipathak, D., Williams, P., Kadel, E. E., Koeppen, H., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0860-1 · Cited by 429
Emerging cytokine networks in colorectal cancer
West, N. R., McCuaig, S., Franchini, F., & Powrie, F. (2015) · Nature Reviews Immunology · doi:10.1038/nri3896 · Cited by 396
Interleukin-8 in cancer pathogenesis, treatment and follow-up
Alfaro, C., Sanmamed, M. F., Rodríguez-Ruiz, M. E., Teijeira, Á., Oñate, C., González, Á., Ponz, M., Schalper, K. A., Pérez-Gracia, J. L., & Melero, I. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.08.004 · Cited by 372
Fousek, K., Horn, L. A., & Palena, C. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107692 · Cited by 359
Metadata
- Authors
- Lee, Y. S., Choi, I., Ning, Y., Kim, N. Y., Khatchadourian, V, Yang, D., Chung, H. K., Choi, D., LaBonte, M. J., Ladner, R. D., Nagulapalli Venkata, K. C., Rosenberg, D. O., Petasis, N. A., Lenz, H.-J., & Hong, Y.-K.
- Venue
- British Journal of Cancer
- Published
- 2012-05
- Volume
- 106
- Issue
- 11
- Pages
- 1833-1841
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1965065360
- Cited by
- 292
- References
- 40
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.